Brca1 Gene Mutation clinical trials

Explore recruiting brca1 gene mutation clinical trials.

Recruiting brca1 gene mutation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Brca1 Gene Mutation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

BRCA-P: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, International Phase 3 Study to Determine the Preventive Effect of Denosumab on Breast Cancer in Women Carrying a BRCA1 Germline Mutation

Spain, Germany, Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Brca1 Gene Mutation trials by city

Brca1 Gene Mutation in Toronto Brca1 Gene Mutation in Vancouver Brca1 Gene Mutation in Montreal Brca1 Gene Mutation in Calgary Brca1 Gene Mutation in Edmonton Brca1 Gene Mutation in Ottawa Brca1 Gene Mutation in Winnipeg Brca1 Gene Mutation in Quebec City Brca1 Gene Mutation in Hamilton Brca1 Gene Mutation in Kitchener Brca1 Gene Mutation in London Brca1 Gene Mutation in Halifax Brca1 Gene Mutation in New York Brca1 Gene Mutation in Los Angeles Brca1 Gene Mutation in Chicago Brca1 Gene Mutation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease